Literature DB >> 27464320

Psychometric Reevaluation of the Columbia-Suicide Severity Rating Scale: Findings From a Prospective, Inpatient Cohort of Severely Mentally Ill Adults.

Alok Madan1,2,3, B Christopher Frueh2,4, Jon G Allen2,3, Thomas E Ellis2,3, Katrina A Rufino2,5, John M Oldham2,3, J Christopher Fowler2,3.   

Abstract

OBJECTIVE: Accurate prediction of suicide remains elusive due to lack of predictive measures. Given the Columbia-Suicide Severity Rating Scale's (C-SSRS) emerging "gold-standard" status for risk assessment, studies are needed to assess its psychometric properties, particularly predictive validity. The current study adds to the limited literature by assessing the C-SSRS's internal consistency, factor structure, concurrent validity, and predictive validity.
METHODS: In this longitudinal study of 1,055 adults with DSM-IV diagnoses consecutively admitted to a specialized psychiatric hospital between July 1, 2012, and June 30, 2014, patients completed standardized assessments, including the C-SSRS, at admission and 2, 12, and 24 weeks postdischarge.
RESULTS: The C-SSRS evidenced excellent internal consistency (ordinal α = .95). Principal components analysis (PCA) revealed a 2-factor solution, accounting for 65.3% of the variance across items. The severity of ideation and behavioral items loaded onto the first factor, and the intensity of ideation items loaded onto the second factor. The total score, factors, and the most severe ideation single item were moderately correlated with other measures of suicidality (0.27 ≤ r ≤ 0.58; P < .0001). The summary score from the ideation/behavior factor was found to be modestly correlated with any suicide-related behavior within the 6 months following hospitalization. Receiver operator characteristics indicated that the C-SSRS performed adequately in correctly classifying any suicide-related behavior within 6 months of discharge from the hospital (AUC = 0.757, P < .001) with the total score and summary score from the ideation/behavior factor providing the best balance between sensitivity (0.694) and specificity (0.652-0.674).
CONCLUSIONS: This study is the first to assess the factor structure of the C-SSRS in a large, high-risk sample. The measure has solid psychometric properties and merits use as a suicide risk assessment measure. © Copyright 2016 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27464320     DOI: 10.4088/JCP.15m10069

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  11 in total

1.  Calculated Decisions: Columbia-Suicide Severity Rating Scale (C-SSRS)

Authors:  Joshua Salvi
Journal:  Emerg Med Pract       Date:  2019-05-01

2.  C-SSRS performance in emergency department patients at high risk for suicide.

Authors:  Lily A Brown; Edwin D Boudreaux; Sarah A Arias; Ivan W Miller; Alexis M May; Carlos A Camargo; Craig J Bryan; Michael F Armey
Journal:  Suicide Life Threat Behav       Date:  2020-07-24

3.  If You Listen, I Will Talk: the Experience of Being Asked About Suicidality During Routine Primary Care.

Authors:  Julie E Richards; Sarah D Hohl; Ursula Whiteside; Evette J Ludman; David C Grossman; Greg E Simon; Susan M Shortreed; Amy K Lee; Rebecca Parrish; Mary Shea; Ryan M Caldeiro; Robert B Penfold; Emily C Williams
Journal:  J Gen Intern Med       Date:  2019-07-25       Impact factor: 5.128

4.  Improving function through primary care treatment of PTSD: The IMPACT study protocol.

Authors:  Sheila A M Rauch; H Myra Kim; Ron Acierno; Carly Ragin; Bethany Wangelin; Kimberly Blitch; Wendy Muzzy; Stephanie Hart; Kara Zivin; Jeffrey Cigrang
Journal:  Contemp Clin Trials       Date:  2022-08-12       Impact factor: 2.261

5.  An implementation evaluation of "Zero Suicide" using normalization process theory to support high-quality care for patients at risk of suicide.

Authors:  Julie E Richards; Gregory E Simon; Jennifer M Boggs; Rinad Beidas; Bobbi Jo H Yarborough; Karen J Coleman; Stacy A Sterling; Arne Beck; Jean P Flores; Cambria Bruschke; Julie Goldstein Grumet; Christine C Stewart; Michael Schoenbaum; Joslyn Westphal; Brian K Ahmedani
Journal:  Implement Res Pract       Date:  2021-05-24

Review 6.  Using categorical data analyses in suicide research: Considering clinical utility and practicality.

Authors:  Sean M Mitchell; Ian Cero; Andrew K Littlefield; Sarah L Brown
Journal:  Suicide Life Threat Behav       Date:  2021-02

7.  Efficacy and Safety of PRC-063, Extended-Release Multilayer Methylphenidate in Adults with ADHD Including 6-Month Open-Label Extension.

Authors:  Margaret D Weiss; Ann C Childress; Graeme A E Donnelly
Journal:  J Atten Disord       Date:  2020-01-09       Impact factor: 3.256

8.  Internet videoconferencing delivered cognitive behavior therapy for generalized anxiety disorder: protocol for a randomized controlled trial.

Authors:  Vesna Trenoska Basile; Toby Newton-John; Bethany M Wootton
Journal:  Trials       Date:  2022-07-23       Impact factor: 2.728

9.  Short term risk of non-fatal and fatal suicidal behaviours: the predictive validity of the Columbia-Suicide Severity Rating Scale in a Swedish adult psychiatric population with a recent episode of self-harm.

Authors:  Åsa U Lindh; Margda Waern; Karin Beckman; Ellinor Salander Renberg; Marie Dahlin; Bo Runeson
Journal:  BMC Psychiatry       Date:  2018-10-01       Impact factor: 3.630

10.  Asenapine in the Treatment of Bipolar Depression.

Authors:  Rif S El-Mallakh; Sharon Nuss; Dong Gao; Yonglin Gao; Surriya Colleen Ahmad; Clare Schrodt; Caleb Adler
Journal:  Psychopharmacol Bull       Date:  2020-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.